Advertisement

American Journal of Clinical Dermatology

, Volume 1, Issue 4, pp 211–215 | Cite as

The Antibacterial-Corticosteroid Combination

What is its Role in Atopic Dermatitis?
  • Richard E. A. Williams
Leading Article

Abstract

The role of Staphylococcus aureus and therefore the place of combined antistaphylococcal and corticosteroid therapy in atopic dermatitis remains uncertain. While overt secondary infections such as furunculosis and impetigo respond rapidly to antibacterials, there is conflicting evidence as to the effect of antistaphylococcal therapy in atopic dermatitis that is not overtly infected. It is unlikely that antibacterials contribute to the management of mild atopic dermatitis. In more severe cases higher densities of S. aureus colonization are present. Antibacterials, whether topical or systemic, in combination with topical corticosteroids, may produce a more rapid decrease in S. aureus colonization than topical corticosteroids alone. Evidence for an accompanying greater speed in clinical improvement of the dermatitis is, however, mostly lacking.

Topical antibacterial-corticosteroid combinations can be useful when treating small areas of skin for a limited period of time but are accompanied by the risk of sensitization and the emergence of resistant strains of bacteria. Systemic antibacterials in combination with topical corticosteroid are more appropriate when larger areas are involved.

Keywords

Dermatitis Atopic Dermatitis Topical Corticosteroid Allergic Contact Dermatitis Mupirocin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Leyden J.J., Marples R.R., Kligman A.M. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90: 525–530PubMedCrossRefGoogle Scholar
  2. 2.
    Williams R.E.A., Gibson A.G., Aitchison T.C., et al. Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990; 123: 493–501PubMedCrossRefGoogle Scholar
  3. 3.
    Bibel D.J., Aly R., Shinefield H.R., et al. The Staphylococcus aureus receptor for fibronectin. J Invest Dermatol 1983; 80: 494–496PubMedCrossRefGoogle Scholar
  4. 4.
    Hay R.J., Adriaans B.M. Bacterial infections. In: Champion R.H., Burton J.L., Burns D.A., et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 1097–1179Google Scholar
  5. 5.
    Veien N.K. Antibiotics in bacterial skin infections. Br J Dermatol 1998; 139 Suppl. 53: 30–36PubMedCrossRefGoogle Scholar
  6. 6.
    White M.I., Noble W.C. The cutaneous reaction to staphylococcal protein A in patients with atopic dermatitis or psoriasis. Br J Dermatol 1985; 113: 179–183PubMedCrossRefGoogle Scholar
  7. 7.
    McFadden J.P., Noble W.C., Camp R.D.R. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128: 631–632PubMedCrossRefGoogle Scholar
  8. 8.
    Jappe U., Heuck D., Witte W., et al. Superantigen production by Staphylococcus aureus in atopic dermatitis: no more than a coincidence? [letter]. J Invest Dermatol 1998 May; 110 (5): 844–886PubMedCrossRefGoogle Scholar
  9. 9.
    Zollner T.M., Kaufmann R. Superantigens in T cell mediated skin diseases — more than a coincidence [letter; comment]. J Invest Dermatol 1999 Jan; 112 (1): 118–119PubMedCrossRefGoogle Scholar
  10. 10.
    Wachs G.N., Maibach H.I. Co-operative double-blind trial of an antibiotic/corticoid combination in impetiginised atopic dermatitis. Br J Dermatol 1976; 95: 323–328PubMedCrossRefGoogle Scholar
  11. 11.
    Leyden J.J., Kligman A.M. The case for steroid-antibiotic combinations. Br J Dermatol 1977; 96: 179–187PubMedCrossRefGoogle Scholar
  12. 12.
    Lever R., Hadley K., Downey D., et al. Staphylococcal colonisation in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988; 119: 189–198PubMedCrossRefGoogle Scholar
  13. 13.
    Ramsay C.A., Savoie J.M., Gilbert M. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. J Eur Acad Dermatol Venereol 1996; 7 Suppl. 1: S15–S22CrossRefGoogle Scholar
  14. 14.
    Hjorth N., Schmidt H., Thomasen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica 1985; 4: 126–131PubMedGoogle Scholar
  15. 15.
    Hill V.A., Wong E., Corbett M.F., et al. Comparative efficacy of betamethasone/clioquinol (Betnovate-C) cream and betamethasone/fusidic acid (Fucibet) cream in the treatment of infected hand eczema. J Dermatol Treatment 1998; 9: 15–19CrossRefGoogle Scholar
  16. 16.
    Poyner T.F., Dass B.K. Comparative efficacy and tolerability of fusidic acid/hydrocortisone cream (Fucidin H cream) and miconazole/hydrocortisone cream (Daktacort cream) in infected eczema. J Eur Acad Dermatol Venereol 1996; 7 Suppl. 1: S23–S30CrossRefGoogle Scholar
  17. 17.
    Meenan F.O.C. A double-blind comparative study to compare the efficacy of Locoid C with Tri-Adcortyl in children with infected eczema. Br J Clin Pract 1988; 42: 200–202PubMedGoogle Scholar
  18. 18.
    Jaffe G.V., Grimshaw J.J. A clinical trial of hydrocortisone/potassium hydroxyquinolone sulphate (Quinocort) in the treatment of infected eczema and impetigo in general practice. Pharmatherapeutica 1986; 4: 628–636PubMedGoogle Scholar
  19. 19.
    Noble W.C. Skin bacteriology and the role of Staphylococcus aureus in infection. Br J Dermatol 1998; 139 Suppl. 53: 9–12PubMedCrossRefGoogle Scholar
  20. 20.
    Ewing C.I., Ashcroft C., Gibbs A.C.C., et al. Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998; 138: 1022–1029PubMedCrossRefGoogle Scholar
  21. 21.
    Charman C. Clinical evidence: atopic eczema. BMJ 1999; 318: 1600–1604PubMedCrossRefGoogle Scholar
  22. 22.
    White M.I., Noble W.C. Consequences of colonisation and infection by Staphylococcus aureus in atopic dermatitis. Clin Exp Dermatol 1986; 11: 34–40PubMedCrossRefGoogle Scholar
  23. 23.
    Nilsson E.J., Henning C.G., Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992; 27: 29–34PubMedCrossRefGoogle Scholar
  24. 24.
    Stadler J.F., Fleury M., Sourisse M., et al. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994; 131: 536–540Google Scholar
  25. 25.
    Slack R.C.B. Topical use of antimicrobial agents. In: Greenwood D., editor. Antimicrobial chemotherapy. Oxford: Oxford University Press, 1995; 387–394Google Scholar
  26. 26.
    Jackson D., Tasker T.C.G., Sutherland R., et al. Clinical pharmacology of Bactroban: pharmacokinetics, tolerance and efficacy studies. Curr Clin Pract 1985; 16: 54–67Google Scholar
  27. 27.
    Wilkinson J.D., Shaw S. Contact dermatitis: allergic. In: Champion R.H., Burton J.L., Burns D.A., et al., editors. Rook/Wilkinson/Ebling textbook of dermatology. Oxford: Blackwell Science, 1998: 733–819Google Scholar
  28. 28.
    Wakelin S.H., Shaw S., Marren S., et al. Allergic contact dermatitis to newer topical anti-staphylococcal agents [abstract]. Br J Dermatol 1996; 135 Suppl. 47: 17Google Scholar
  29. 29.
    Smith R.J., Alder V.G., Warin R.P. Pyogenic cocci in infantile eczema throughout one year. BMJ 1975; 3: 199–201PubMedCrossRefGoogle Scholar
  30. 30.
    Simpson-Dent S.L., Hunt S.J., Hardman C., et al. Rates of fusidic acid resistance in paediatric dermatology patients — a 6-year study. Br J Dermatol 2000; 143 Suppl. 57: 127Google Scholar
  31. 31.
    Ravenscroft J.C., Layton A., Murtagh M., et al. Study to assess the effect of short-term topical fusidic acid resistant (FusR) S. aureus in eczema patients. Br J Dermatol 2000; 143 Suppl. 57: 68–69Google Scholar
  32. 32.
    Chu T. Audit of new referrals with atopic dermatitis over a two month period. In: Hobbs F.D.R., editor. Managing Staphylococcus aureus in eczema. London: Royal Society of Medicine Press, 1999 (Round table Series 61): 7–14Google Scholar

Copyright information

© Adis International Limited 2000

Authors and Affiliations

  • Richard E. A. Williams
    • 1
  1. 1.Glan Clwyd HospitalWalesUK

Personalised recommendations